Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia. Issue 2 (4th December 2017) - Walter, Roland B.; Michaelis, Laura C.; Othus, Megan; Uy, Geoffrey L.; Radich, Jerald P.; Little, Richard F.; Hita, Sandi; Saini, Lalit; Foran, James M.; Gerds, Aaron T.; Klepin, Heidi D.; Hay, Annette E.; et al.